Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials
Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial
ConclusionsSimulated activation is useful as a means to test, and prepare for, the rapid activation of ‘hibernating’ research studies. Whether simulation exercises can also help reduce waste in complex clinical trial research deserves further exploration.Trial registrationEudraCT Number 2013-001051-12,ISRCTN72331452. Registered on 6 March 2013. (Source: Trials)
Source: Trials - November 16, 2017 Category: Research Source Type: clinical trials
Recombinant H7 Hemagglutinin Influenza Vaccine Trial
Condition: Influenza, Avian Intervention: Biological: Recombinant influenza hemagglutinin Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute Recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2017 Category: Research Source Type: clinical trials
